Cosmo First Earnings Call Transcript: Key Takeaways
Consolidated revenue ₹1,388 Cr (+51% YoY) on 15% volume; EBITDA ₹177 Cr (+38%) includes ~₹18 Cr net one-offs, normalized +24%.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Consolidated revenue ₹1,388 Cr (+51% YoY) on 15% volume; EBITDA ₹177 Cr (+38%) includes ~₹18 Cr net one-offs, normalized +24%.
Q2 FY27 revenue ₹1,388 Cr (+51% YoY), EBITDA ₹177 Cr (12.8% margin), PAT ₹99 Cr (+111%, tax-aided). Net debt/EBITDA down to 1.9x from 3.0x; specialty mix improving.
Cosmo First released Q2 FY27 consolidated results via press release, showing EBITDA and PAT growth. Net debt was reduced while B2B and consumer businesses scaled up.
Cosmo First Ltd reported revenue from operations of ₹1,388 Cr (+51.0% YoY) and net profit of ₹98.6 Cr (+111.1% YoY) for Q2 FY27.
COSMO FIRST Limited will hold a board meeting on 03-Nov-2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. Trading window closes from 01-Oct-2026 until 48 hours after results are published.
Cosmo First Limited is acquiring Prolife Speciality Vet Clinic LLP for a cash consideration of ₹6.10 Crore to expand its Petcare division, Zigly.
Cosmo First Ltd will acquire Prolife Speciality Vet Clinic LLP in Mumbai via a slump sale to expand its petcare division. Consideration terms were not disclosed.